Rabbit Recombinant Monoclonal NFYA antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Human samples. Cited in 5 publications.
View Alternative Names
Nuclear transcription factor Y subunit alpha, CAAT box DNA-binding protein subunit A, Nuclear transcription factor Y subunit A, NF-YA, NFYA
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-NFYA antibody [EPR9061] (AB139402)
ab139402 stained Malme-3M cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab139402 at 1μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-NFYA antibody [EPR9061] (AB139402)
Intracellular flow cytometrical analysis of permeabilized NIH 3T3 cells labelling NFYA with ab139402 at 1/10 dilution (red) or a rabbit IgG (negative) (green).
- WB
Unknown
Western blot - Anti-NFYA antibody [EPR9061] (AB139402)
All lanes:
Western blot - Anti-NFYA antibody [EPR9061] (ab139402) at 1/1000 dilution
Lane 1:
NIH/3T3 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
293T (Human embryonic kidney epithelial cell) cell lysate at 10 µg
Lane 4:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 37 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Journal of extracellular vesicles 14:e70088 PubMed40511723
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 15:528 PubMed39367986
2024
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e22779 PubMed36723798
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 78:752-764.e6 PubMed32333838
2020
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology progress 34:1581-1588 PubMed30294957
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com